Skip to content

Eye3

About Eye3

Eye3, a medical device company addressing the unmet needs of the drug testing market with a mobile drug screening platform.

Their problem

In 2018, Eye3 sought Innovation Factory’s help in recruiting a C-Level employee, protecting its flagship product, and accessing advisory support from life sciences industry experts.

Our solution

Innovation Factory offered Eye3 a wide array of support including access to free market intelligence, commercialization guidance, intellectual property protection assistance, strategic connections, and funding through iF’s Southern Ontario Pharmaceutical and Health Innovation Ecosystem (SOPHIE) program.

Company success

Eye3, continues to leverage Innovation Factory’s resources to drive their product commercialization. They have gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.

Testimonial

“The support that we received from Innovation Factory and their life science network were critical to our business. They helped us develop a business framework and establish connections that have been integral to defining our overall direction and supporting our growth at every stage to date.”

David Wilson, Founder

Discover more case studies

Find out how Innovation Factory is helping companies like these overcome obstacles to to scale their business success and access further growth opportunities.

Our website uses cookies to ensure you get the best experience. Learn more about the policy

i.d.e.a. Fund Applications Open

Applications are now open for i.d.e.a. Fund Cohort 4

Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?

The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.

Applications are open from June 16 to July 7, 2025.